OU's Trading Corner (OTC)/ Now CDN Stocks and US Blue Chips (sorta)

[originunknown]

Covalon gets patent for therapeutic hydrogel delivery

2008-03-27 07:51 ET - News Release

Dr. Frank DiCosmo reports

COVALON RECEIVES CANADIAN PATENT FOR DRUG DELIVERY VIA THERAPEUTIC HYDROGELS

Covalon Technologies Ltd. has received a notice of allowance for a Canadian patent entitled drug delivery via therapeutic hydrogels (patent application No. 2,286,644).

The technology can be used for site-specific delivery of several drugs in a time-release fashion from combination medical devices. The patent augments and strengthens Covalon's technology position in the expanding area of combination medical devices. The devices that may benefit from the technology include implantable medical devices, wound closure systems and wound dressings, which can contain a variety of active agents such as antibiotics, hormones, growth factors and other therapeutics that are beneficial for the medical condition under management.